| 期刊全称 | Cancer and Metastasis Reviews |
|---|
| 期刊缩写 | CANCER METAST REV |
|---|
| 涉及主题 | 医学生物遗传学内科学癌症化学生物化学癌症研究基因病理细胞生物学免疫学转移物理有机化学 |
|---|
| 期刊介绍 | Contemporary biomedical research is on the threshold of an era in which physiological and pathological processes can be analyzed in increasingly precise and mechanistic terms. The transformation of biology from a largely descriptive, phenomenological discipline to one in which the regulatory principles can be understood and manipulated with predictability brings a new dimension to the study of cancer and the search for effective therapeutic modalities for this disease. Cancer and Metastasis Reviews provides a forum for critical review and discussion of these challenging developments. Each issue of Cancer and Metastasis Reviews is devoted to a particular theme or topic and will contain from five to seven different contributions. In addition, an introductory preface is included from an individual who is distinguished in the field to be covered. The topics and contributors are chosen by the Editor-in-Chief after consultation with various members of the Editorial Advisory Board. Special emphasis is placed on subjects which are of relevance to the molecular and cellular biology of cancer metastasis and tumor progression, as well as to the treatment of metastatic disease. Occasional issues will be devoted to an in-depth clinical and biological analysis of a particular type of cancer. A major function of the journal is to review some of the more important and interesting recent developments in the biology and treatment of malignant disease, as well as to highlight new and promising directions, be they technological or conceptual. Contributors are encouraged to review their personal work and be speculative. |
|---|
| 期刊ISSN | print: 0167-7659 |
|---|
| 历年影响因子 | | 2024年 | 2023年 | 2022年 | 2021年 | 2020年 | 2019年 | 2018年 | 2017年 |
|---|
| 7.7 | 9.2 | 9.237 | 9.264 | 6.4 | 6.667 | 6.081 | 4.697 |
|
|---|
| 历年发表/被引量 | | 年份 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|
| 发表量 | 41 | 79 | 85 | 55 | 74 | 97 | 61 | 56 | 63 | 48 | 59 | 67 | 50 | 72 | | 被引量 | 4216 | 8945 | 9936 | 9710 | 9849 | 9127 | 7340 | 6943 | 7030 | 6859 | 6779 | 7182 | 7040 | 6644 |
|
|---|
| h-Index | 134 |
|---|
| 自引率 | 1.30% |
|---|
| 涉及的研究领域 | 医学-肿瘤学 |
|---|
| 中科院2025年分区 ? | |
|---|
| WOS期刊分区 | JCR学科分类| JCR分区学科名称 | 收录数据库 | JCR分区 | 分区排名 |
|---|
| ONCOLOGY | SCIE | Q1 | 34/326 |
JCI学科分类| JCI分区学科名称 | 收录数据库 | JCI分区 | 分区排名 |
|---|
| ONCOLOGY | SCIE | Q1 | 62/326 |
|
|---|
| 期刊主页 | https://www.springer.com/10555https://www.springer.com/journal/10555 |
|---|
| 投稿网址 | https://www.editorialmanager.com/canc |
|---|
| 出版商 | Springer US |
|---|
| 出版国家(地区) | UNITED STATES |
|---|
| 出版语言 | English |
|---|
| 出版周期 | Quarterly |
|---|
| 每年出版文章数 | 59 |
|---|
| Gold OA文章占比 | 43.10% |
|---|
原创研究文献占比 (排除综述) | 0.00% |
|---|
| SCI收录类型 | Science Citation Index Expanded (SCIE) Scopus (CiteScore) |
|---|
| PubMed链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0167-7659%5BISSN%5D |
|---|
| 平均审稿周期 | 较慢,6-12周 |
|---|
| 平均录用比例 | 较难 |
|---|
| 相关链接 | 您可以在上述网站查看该期刊的网友互动,及期刊影响力的其它指标。 |
|---|